Design Therapeutics, Inc. (DSGN)
NASDAQ · Healthcare
Design Therapeutics, Inc. Shareholder Equity 2020–2025
Design Therapeutics, Inc. annual shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Design Therapeutics, Inc. shareholder equity as of December 31, 2025: 212.5M, a 12.22% decrease year-over-year.
- Design Therapeutics, Inc. shareholder equity for 2025 were 212.5M, a 12.22% decrease from 2024.
- Design Therapeutics, Inc. shareholder equity for 2024 were 242.1M, a 2239.61% decrease from 2020.
- Design Therapeutics, Inc. shareholder equity for 2020 were -11.3M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Design Therapeutics, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $213 |
| 2024 | $242 |
| 2020 | $-11 |
Design Therapeutics, Inc. Shareholder Equity — FAQ
Design Therapeutics, Inc. (DSGN) shareholder equity over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see DSGN's shareholder equity history?
The chart and table above show Design Therapeutics, Inc.'s shareholder equity by year and by quarter, including the growth rate.